4//SEC Filing
Barclay Alec 4
Accession 0000899243-22-007494
CIK 0001492674other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 7:42 PM ET
Size
11.0 KB
Accession
0000899243-22-007494
Insider Transaction Report
Form 4
Barclay Alec
SVP, Operations
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-02-21−10,000→ 0 total→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2021-02-21+10,000→ 84,420 total - Tax Payment
Common Stock
2021-02-21$0.47/sh−5,275$2,458→ 79,145 total - Award
Restricted Stock Units
2022-02-20+600,000→ 600,000 total→ Common Stock (600,000 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]5,275 shares of common stock were automatically withheld at vesting to cover required tax withholding.
- [F3]On February 20, 2022 the reporting person was granted 600,000 RSU's that vest in three equal annual installments commencing on February 20, 2022.
- [F4]On February 21, 2019 the reporting person was granted 30,000 RSU's that vest in three equal annual installments commencing on February 21, 2020..
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001734339
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 7:42 PM ET
- Size
- 11.0 KB